Home

helps physicians and healthcare professionals

Erectile Dysfunction

helps physicians and healthcare professionals

Doctor123.org

helps physicians and healthcare professionals

Visual Loss, Emergency Medicine


Basics


Description


  • Decrease in visual function (i.e., visual acuity, visual fields, blurry vision)
  • Visual loss has many etiologies and can be caused by multiple body systems

Etiology


  • Ophthalmologic:
    • Eyelid or tear film abnormality
    • Anterior segment (cornea, anterior chamber, iris, lens)
    • Posterior segment (vitreous, retina, optic nerve)
    • Posterior to the eye (optic nerve, chiasm, radiations)
  • Traumatic:
    • Corneal abrasion
    • Hyphema
    • Lens dislocation
    • Ruptured globe
    • Commotio retinae
    • Retinal detachment
    • Retinal/vitreous hemorrhage
    • Retrobulbar hemorrhage
    • Intraocular foreign body
  • Neurologic:
    • Cerebral (cerebrovascular accident [CVA]) or intracranial pathology (mass lesion)
    • Multiple sclerosis
    • Optic neuritis
    • Migraine
  • Cardiovascular system:
    • Embolic
    • Thrombotic
    • Ischemic
    • Hypertensive events
  • Immunologic system:
    • Uveitis
    • Giant cell arteritis
  • Infection:
    • Orbital cellulitis/abscess
    • Cavernous sinus thrombosis
    • HIV optic neuropathy or cytomegalovirus (CMV) retinitis
  • Endocrine:
    • Diabetic retinopathy
    • Thyroid disease may cause diplopia (muscle hypertrophy) or corneal erosions
  • Toxic:
    • Methanol (acute severe loss, subacute optic atrophy)
    • Licorice (transient loss, self-limited)
    • Digitalis (flashing lights, color changes)
    • Amiodarone (rare cause of optic neuropathy)

Diagnosis


  • Categorize visual loss by the properties associated with the decrease in visual function
  • Transient (<24 hr):
    • Minutes:
      • Transient ischemic attack = amaurosis fugax (unilateral)
      • Vertebrobasilar artery insufficiency (bilateral)
    • Minutes to hours:
      • Migraine
      • Sudden BP changes
  • Persistent (>24 hr):
    • Painless: Sudden:
      • Retinal artery or vein occlusion
      • Vitreous hemorrhage
      • Retinal detachment
      • Optic neuritis
      • Giant cell arteritis
      • Cerebral infarct
    • Painless: Gradual (weeks to years):
      • Cataract
      • Presbyopia
      • Refraction errors
      • Open-angle glaucoma
      • Chronic retinal disease
      • Macular degeneration
      • Diabetic retinopathy
      • CMV retinopathy
      • CNS tumor
    • Painful:
      • Corneal abrasion, ulcer, burn, or foreign body
      • Angle-closure glaucoma
      • Optic neuritis
      • Iritis/uveitis/endophthalmitis
      • Keratoconus with hydrops
      • Orbital cellulitis/abscess
  • Monocular: Pathology anterior to optic chiasm
  • Binocular: Pathology posterior to optic chiasm
  • Associated with systemic neurologic symptoms of visual field defects:
    • CVA (especially posterior or occipital circulation)
    • Mass lesion (pituitary adenomas, aneurysm, meningioma, other tumors)
  • Malingering/hysteria

Signs and Symptoms


History
  • Decreased vision:
    • Loss of vision
    • Blurry vision
    • Double vision:
      • Horizontal or vertical
  • History of trauma
  • Use of corrective lenses:
    • Contacts
    • Glasses
  • Prior eye surgery or problems
  • Eye pain
  • Conjunctival redness or discharge
  • New floaters
  • Flashing lights
  • Pain with eye movement
  • Key elements to determine:
    • Acute or gradual onset
    • Length of symptoms
    • Transient vision loss or permanent
    • Binocular or monocular
    • Degree of vision loss
    • Painful or painless
    • Other comorbidities

Physical Exam
  • Ophthalmologic:
    • Visual acuity
    • Pupil exam
    • Afferent papillary defect
    • Confrontational visual field exam
    • Extraocular muscle function
    • Slit-lamp exam
    • Intraocular pressure (Tonometry)
    • Fundoscopy:
      • Optic nerve swelling
      • Pale retina with a cherry-red spot
  • Cardiovascular:
    • Murmurs
    • Carotid bruits
    • Temporal artery tenderness
  • Neurologic exam:
    • Complete exam for other deficits
    • Optic chiasm and intracerebral lesions
    • Occipital and posterior circulation lesions
  • General:
    • Signs of immune, endocrine, or toxic disorders

Essential Workup


Thorough history and physical exam ‚  

Diagnosis Tests & Interpretation


Lab
  • May be obtained to determine extent of other comorbidities in association with vision loss (i.e., diabetes, cardiovascular disease)
  • Erythrocyte sedimentation rate if giant cell arteritis is suspected

Imaging
  • Tests should be directed toward the suspected etiology of visual loss
  • Dilated fundus exam may be performed to assess for posterior segment disease
  • Temporal artery biopsy may be obtained if giant cell arteritis is suspected
  • Brain CT, MRI, MRA, and transcranial Doppler may be used to evaluate neurologic symptoms and vertebrobasilar artery
  • Urgent cardiac and carotid US if a retinal artery occlusion is diagnosed
  • Facial CT may be used to evaluate extent of traumatic injuries

Differential Diagnosis


  • Trauma
  • Neurologic lesion
  • Infectious
  • Cardiovascular
  • Toxic/metabolic
  • Autoimmune

Treatment


Pre-Hospital


  • Chemical burns:
    • Begin copious irrigation with water or saline

Ed Treatment/Procedures


  • Direct therapy toward cause of visual loss
  • Ophthalmology consultation for visual loss with an uncertain diagnosis
  • 3 conditions for which identification and treatment must begin within minutes:
    • Central retinal artery occlusion
    • Chemical burn
    • Acute angle-closure glaucoma

Central Retinal Artery Occlusion
  • Clinical criteria:
    • Unilateral, painless, dramatic vision loss
    • Afferent pupillary defect
    • Pale fundus with a cherry-red spot (macula)
    • Counting fingers to light perception in 94% of patients
  • Therapy:
    • Immediate ophthalmology consultation
    • Maneuvers and medications to lower intraocular pressure, allowing the embolus to move to the periphery:
      • Ocular massage: Direct pressure to eye for 5 " “15 sec then sudden release, repeat for 15 min
      • Acetazolamide: 500 mg IV or PO
      • Topical Ž ²-blocker
      • Anterior chamber paracentesis by an ophthalmologist
    • Referral for cardiac and carotid artery workup
    • Rule out giant cell arteritis

Chemical Burn
  • Clinical criteria:
    • Alkali worse than acids
    • White eye (vessels have already sloughed) worse than red eye (vessels are intact)
    • Examples: Mace, cements, plasters, solvents
  • Therapy:
    • Topical anesthetic
    • Copious irrigation of the eyes with LR or NS (nonsterile water is acceptable if others not available); minimum of 30 min
    • Goal: Neutral pH at 5 " “10 min after ending irrigation
    • Do not try to neutralize acids with alkalis or vice versa
    • Evert lids and use moist cotton-tipped applicator to sweep furnaces for residual chemical precipitants
    • Dilate with cycloplegic (atropine, cyclopentolate, tropicamide)
    • Do not use phenylephrine; vasoconstricts already ischemic conjunctival blood vessels
    • Erythromycin ointment q1 " “2h
    • Artificial tears q1h
    • Check intraocular pressure

Acute Angle-closure Glaucoma
  • Signs and symptoms:
    • Unilateral, painful vision loss
    • Nausea, vomiting, headache
    • Cornea injected, edematous
    • Mid-dilated, sluggish/nonreactive pupil
    • Swollen, "steamy "  lens
    • Cell, flare in a shallow anterior chamber
    • Increased intraocular pressure (>20 mm Hg)
  • Therapy:
    • Topical Ž ²-blocker
    • Topical prostaglandin analog
    • Acetazolamide
    • Topicalα-2 agonist
    • Pilocarpine
    • Mannitol: If no decrease in IOP after 1 hr

Medication


  • Antibiotic drops:
    • Ciprofloxacin 0.3%: 1 " “2 gtt q1 " “6h
    • Gentamicin 0.3%: 1 " “2 gtt q4h
    • Ofloxacin 0.3%: 1 " “2 gtt q1 " “6h
    • Levofloxacin 0.5%: 1 " “2 gtt q2h
    • Polymyxin (Polytrim) 1 gtt q3 " “6h
    • Sulfacetamide 10%, 0.3%: 1 " “2 gtt q2 " “6h
    • Tobramycin 0.3%: 1 " “2 gtt q1 " “4h
    • Trifluridine 1%: 1 gtt q2 " “4h
  • Antibiotic ointments:
    • Bacitracin 500 U/g 1/2 in ribbon q3 " “6h
    • Ciprofloxacin 0.3%: 1/2 in ribbon q6 " “q8h
    • Erythromycin 0.5%: 1/2 in ribbon q3 " “6h
    • Gentamicin 0.3%: 1/2 in ribbon q3 " “4h
    • Neosporin 1/2 in ribbon q3 " “4h
    • Polysporin 1/2in ribbon q3 " “4h
    • Sulfacetamide 10%: 1/2 in ribbon q3 " “8h
    • Tobramycin 0.3%: 1/2 in ribbon q3 " “4h
    • Vidarabine 1/2 in ribbon 5 times per day
  • Mydriatics and cycloplegics:
    • Atropine 1%, 2%: 1 " “2 gtt/day to QID
    • Cyclopentolate 0.5%, 1%, 2%: 1 " “2 gtt PRN
    • Homatropine 2%: 1 " “2 gtt BID " “TID
    • Phenylephrine 0.12%, 2.5%, 10%: 1 " “2 gtt TID " “QID
    • Tropicamide 0.5%, 1%: 1 " “2 gtt PRN dilation
  • Corticosteroid " “antibiotic combination drops (with ophthalmology consultation):
    • Prednisolone (Blephamide) 1 " “2 gtt q1 " “8h
    • Hydrocortisone/neomycin/bacitracin/polymyxin B (Cortisporin) 1 " “2 gtt q3 " “4h
    • Dexamethasone/neomycin/polymyxin B (Maxitrol) 1 " “2 gtt q1 " “8h
    • Prednisolone/gentamicin (Pred-G) 1 " “2 gtt q1 " “8h
    • Dexamethasone/tobramycin/chlorobutanol (TobraDex) 1 " “2 gtt q2 " “26h
  • Glaucoma agents (always with ophthalmology consultation):
    • α-2 agonists:
      • Brimonidine 1% 1 gtt TID
      • Apraclonidine 1% 1 gtt TID
    • Ž ²-blocker:
      • Betaxolol 0.25%, 0.5%: 1 " “2 gtt BID
      • Carteolol 1%: 1 gtt BID
      • Levobunolol 0.25%, 0.5%: 1 gtt QD " “BID
    • Carbonic anhydrase inhibitor:
      • Acetazolamide 500 mg PO/IV QD " “QID
    • Miotic (parasympathomimetic):
      • Pilocarpine 0.25%, 0.5%, 1%, 2%, 3%, 4%, 6%, 8%, 10%: 1 " “2 gtt TID " “QID
    • Osmotic agent:
      • Mannitol 1 " “2 g/kg IV over 45 min
    • Prostaglandin analog:
      • Latanoprost 0.005%: 1 gtt QD
  • Only if mechanical closure is ruled out:
    • Timolol 0.25%, 0.5%: 1 gtt BID

Follow-Up


Disposition


Admission Criteria
  • Ruptured globe
  • Hyphema (depending on severity)
  • Orbital cellulitis/abscess
  • Cavernous sinus thrombosis
  • Significant cardiac, carotid, or neurologic disease
  • Unexplained, progressive vision loss

Discharge Criteria
If the diagnosis is certain and visual loss will not progress ‚  

Follow-Up Recommendations


  • Follow-up should be discussed with ophthalmology for emergent or urgent issues
  • Referral for cardiac and carotid workup in embolic disease

Pearls and Pitfalls


  • Document visual acuity for all eye complaints
  • Topical anesthesia will aid in diagnosis as well as facilitating a proper eye exam
  • Consider ocular issues and a detailed eye exam with headache complaints

Additional Reading


  • Khare ‚  GD, Symons ‚  RC, Do ‚  DV. Common ophthalmic emergencies. Int J Clin Pract.  2008;62:1776 " “1784.
  • Kunimoto ‚  DY, Kanitkar ‚  KD, Makar ‚  MS. The Wills Eye Manual: Office and Emergency Room Diagnosis and Treatment of Eye Disease. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004. Website: www.eyeatlas.com
  • Mahmood ‚  AR, Narang ‚  AT. Diagnosis and management of the acute red eye. Emerg Med Clin North Am.  2008;26:35 " “55.
  • Vortmann ‚  M, Schneider ‚  JI. Acute monocular visual loss. Emerg Med Clin North Am.  2008;26:73 " “96.

See Also (Topic, Algorithm, Electronic Media Element)


  • Chalazion
  • Conjunctivitis
  • Corneal Abrasion
  • Corneal Burn
  • Corneal Foreign Body
  • Dacryocystitis
  • Giant Cell Arteritis
  • Globe Rupture
  • Hordeolum
  • Hyphema
  • Iritis
  • Red Eye
  • Optic Artery Occlusion
  • Optic Neuritis
  • Orbital Cellulitis
  • Ultraviolet Keratitis
  • Vitreous Hemorrhage

Codes


ICD9


  • 368.8 Other specified visual disturbances
  • 368.11 Sudden visual loss
  • 369.9 Unspecified visual loss
  • 364.41 Hyphema of iris and ciliary body
  • 361.9 Unspecified retinal detachment
  • 377.30 Optic neuritis, unspecified
  • 950.9 Injury to unspecified optic nerve and pathways

ICD10


  • H53.8 Other visual disturbances
  • H53.139 Sudden visual loss, unspecified eye
  • H54.7 Unspecified visual loss
  • H21.00 Hyphema, unspecified eye
  • H33.20 Serous retinal detachment, unspecified eye
  • H46.9 Unspecified optic neuritis
  • S05.90XA Unspecified injury of unspecified eye and orbit, init encntr

SNOMED


  • 421293001 Unexplained visual loss (disorder)
  • 246636008 Hazy vision (disorder)
  • 15203004 Sudden visual loss (disorder)
  • 75229002 Hyphema (disorder)
  • 23653003 Traumatic blindness (disorder)
  • 42059000 Retinal detachment (disorder)
  • 66760008 Optic neuritis (disorder)
Copyright © 2016 - 2017
Doctor123.org | Disclaimer